JP2023539581A5 - - Google Patents
Info
- Publication number
- JP2023539581A5 JP2023539581A5 JP2023512724A JP2023512724A JP2023539581A5 JP 2023539581 A5 JP2023539581 A5 JP 2023539581A5 JP 2023512724 A JP2023512724 A JP 2023512724A JP 2023512724 A JP2023512724 A JP 2023512724A JP 2023539581 A5 JP2023539581 A5 JP 2023539581A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010882873 | 2020-08-28 | ||
| CN202010882873.5 | 2020-08-28 | ||
| CN202110958128 | 2021-08-20 | ||
| CN202110958128.9 | 2021-08-20 | ||
| PCT/CN2021/114911 WO2022042673A1 (zh) | 2020-08-28 | 2021-08-27 | 用于降低异源多肽末端异质性的信号肽 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023539581A JP2023539581A (ja) | 2023-09-15 |
| JP2023539581A5 true JP2023539581A5 (https=) | 2025-10-30 |
| JPWO2022042673A5 JPWO2022042673A5 (https=) | 2025-10-30 |
| JP7817241B2 JP7817241B2 (ja) | 2026-02-18 |
Family
ID=80352714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512724A Active JP7817241B2 (ja) | 2020-08-28 | 2021-08-27 | ヘテロポリペプチドの末端異質性を低減するためのシグナルペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230312725A1 (https=) |
| EP (1) | EP4206222A4 (https=) |
| JP (1) | JP7817241B2 (https=) |
| CN (1) | CN116234814A (https=) |
| CA (1) | CA3191184A1 (https=) |
| TW (1) | TWI889889B (https=) |
| WO (1) | WO2022042673A1 (https=) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2182498A1 (en) * | 1994-02-01 | 1995-08-10 | William J. Larochelle | Fusion proteins that include antibody and nonantibody portions |
| IL140110A0 (en) * | 2000-12-05 | 2002-02-10 | Applied Research Systems | Improvement of homogeneity and secretion of recombinant proteins in mammalian systems |
| AU2003237332A1 (en) * | 2002-06-03 | 2003-12-19 | Centocor, Inc. | Anti-relp fusion antibodies, compositions, methods and uses |
| AR047440A1 (es) * | 2004-01-21 | 2006-01-18 | Novozymes As | Produccion de un anticuerpo monoclonal en un hongo heterocarion o una celula huesped fungal |
| CN101375161A (zh) * | 2006-01-27 | 2009-02-25 | 默克公司 | 靶定金黄色葡萄球菌ORF0657n的抗原结合蛋白 |
| CN101460520B (zh) * | 2006-06-02 | 2012-12-26 | Aveo制药公司 | 肝细胞生长因子(hgf)的结合蛋白质 |
| AR061171A1 (es) | 2006-06-02 | 2008-08-06 | Aveo Pharmaceuticals Inc | Proteinas de union al factor de crecimiento de hepatocitos (fch) |
| AU2008318320B2 (en) | 2007-11-02 | 2014-11-27 | The Johns Hopkins University | Multitype HPV peptide compositions and methods for treatment or prevention of human papillomavirus infection |
| EP2906599B1 (en) * | 2012-10-12 | 2019-07-17 | Agency For Science, Technology And Research | Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics |
| WO2016165762A1 (en) | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| MX2021011489A (es) * | 2019-04-01 | 2021-10-22 | Jiangsu Hengrui Medicine Co | Anticuerpo anti-claudina 18.2 y utilizacion del mismo. |
| CN114341184B (zh) | 2020-02-10 | 2023-04-04 | 北京拓界生物医药科技有限公司 | 抗FcRn抗体、其抗原结合片段及其医药用途 |
| CN113484526B (zh) * | 2021-08-11 | 2024-08-23 | 上海迈晋生物医药科技有限公司 | 一种抗FcRn抗体或其抗原结合片段生物学活性的检测方法 |
-
2021
- 2021-08-27 WO PCT/CN2021/114911 patent/WO2022042673A1/zh not_active Ceased
- 2021-08-27 EP EP21860507.9A patent/EP4206222A4/en active Pending
- 2021-08-27 CN CN202180050556.XA patent/CN116234814A/zh active Pending
- 2021-08-27 TW TW110131910A patent/TWI889889B/zh active
- 2021-08-27 US US18/023,301 patent/US20230312725A1/en active Pending
- 2021-08-27 JP JP2023512724A patent/JP7817241B2/ja active Active
- 2021-08-27 CA CA3191184A patent/CA3191184A1/en active Pending